IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
Description
CONCLUSIONS: Humoral immune response to SARS-CoV-2 infection was impaired in lymphoma patients partly due to anti-CD20 and ASCT treatment. COVID-19 vaccination may be more needed for these patients.